Downloads
Abstract
Background: Cisplatin is a widely used potent chemotherapy agent in the treatments of various malignant tumors in children. However, Cisplatin is reported to have several side effects. A case treated with Cisplatin and having acute kidney injury and posterior reversible encephalopathy syndrome was observed.
Case report: A case of a 6 - years - old boy was diagnosed retroperitoneal neuroblastoma stage 4and was treated with Rapid COJEC regimen. On day 48, after 2 cycles of chemotherapy using Cisplatin, our patient developed hypertension and acute kidney injury. After 3 cycles of Cisplatin, on day 60, he had headache, focal seizure, and transient loss of consciousness. Brain MRI scan revealed edema in the cortical gray and subcortical white matter of the bilateral occipital, parietal and temporal lobes which were hyperintense only on FLAIR images, consistent with posterior reversible encephalopathy syndrome. After 40 days of treatment with fluid and electrolyte balance, renal diet, antihypertensive and anticonvulsant drugs, our patient’s condition has improved. He hasn’t had anyfurther seizure episodes. Blood pressure has been controlled and kidney function has returned to almost normal. His brain MRI showed complete resolution.
Conclusion: Pediatrician oncologists need to promptly detectany side effects while using Cisplatin to manage and switch to other drugs
References
McMahon KR, Rassekh SR, Schultz KR, et al. Epidemiologic Characteristics of Acute Kidney Injury During Cisplatin Infusions in Children Treated for Cancer. JAMA Netw Open. 2020;3(5): e203639.
Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334(8):494-500.
Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 2015; 14:914-25
Vaughn C, Zhang L, Schiff D. Reversible posterior leukoencephalopathy syndrome in cancer. Curr Oncol Rep. 2008;10(1):86-91.
How J, Blattner M, Fowler S, et al. Chemotherapyassociated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the
Literature. Neurologist. 2016;21(6):112-117.
Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015;14(9):914-925.
Fugate JE, Claassen DO, Cloft HJ, et al (2010) Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo
Clin Proc. 85(5):427-432.
Lamy C, Oppenheim C, Mas J.L. Chapter 109 - Posterior reversible encephalopathy syndrome, Handbook of Clinical Neurology, Elsevier.
;1687-1701.
Ruggiero A, Ferrara P, Attinà G, Rizzo D, Riccardi R. Renal toxicity and chemotherapyin children with cancer. Br J Clin Pharmacol. 2017;83(12):2605-2614.
Skinner R. Nephrotoxicity - what do we know and what don’t we know? J Pediatr Hematol Oncol. 2011;33(2):128-34.
Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204-12.
McSweeney KR, Gadanec LK, Qaradakhi T, et al. Mechanisms of Cisplatin - Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations. Cancers (Basel). 2021;13(7):1572.
Manohar S, Leung N. Cisplatin Nephrotoxicity: A Review of the Literature. J Nephrol. 2018;31(1):15-25.
Launay - Vacher V, Rey JB, Isnard - Bagnis C, et al. Prevention of cisplatin nephrotoxicity: State of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Cancer
Chemother Pharmacol. 2008.
Casanova AG, Hernández - Sánchez MT, López - Hernández FJ, et al. Systematic review and meta - analysis of the efficacy of clinically tested
protectants of cisplatin nephrotoxicity. Eur J Clin Pharmacol. 2020;76(1):23-33.
Hamroun A, Lenain R, Bigna JJ, et al. Prevention of Cisplatin - Induced Acute Kidney Injury: A Systematic Review and Meta - Analysis. Drugs.
;79(14):1567-1582.
| Published | 01-01-2025 | |
| Fulltext |
|
|
| Language |
|
|
| Issue | No. 76 (2022) | |
| Section | Case report | |
| DOI | 10.38103/jcmhch.76.3 | |
| Keywords | Hội chứng bệnh lý não sau có hồi phục, tổn thương thận cấp, Cisplatin Posterior reversible encephalopathy syndrome, acute kidney injury, Cisplatin |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2022 Journal of Clinical Medicine Hue Central Hospital